Drugs Made In America Acq...

NASDAQ: DMAA · Real-Time Price · USD
10.11
0.03 (0.30%)
At close: May 05, 2025, 3:35 PM
10.40
2.87%
After-hours: May 05, 2025, 06:29 PM EDT

Drugs Made In America Acquisition Ordinary Shares Revenue

Drugs Made In America Acquisition Ordinary Shares reported an annual revenue of $0, reflecting a undefined% growth. For the quarter ending December 31, 2024, Drugs Made In America Acquisition Ordinary Shares generated $0 in revenue.
Revenue (ttm)
-
Revenue Growth
undefined%
Price / Sales Ratio
undefined
Revenue / Employee
-
Employees
undefined
Market Cap
235.14M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.